FZD5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.548600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.116400E-02
Normal-vs-Stage2
3.123800E-01
Normal-vs-Stage3
6.900600E-01
Normal-vs-Stage4
1.947230E-01
Stage1-vs-Stage2
5.994600E-01
Stage1-vs-Stage3
6.789200E-01
Stage1-vs-Stage4
4.480800E-01
Stage2-vs-Stage3
7.502600E-01
Stage2-vs-Stage4
1.792200E-01
Stage3-vs-Stage4
4.469200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.741400E-01
Normal-vs-AfricanAmerican
2.524600E-01
Normal-vs-Asian
2.907400E-01
Caucasian-vs-AfricanAmerican
8.803600E-01
Caucasian-vs-Asian
3.255600E-01
AfricanAmerican-vs-Asian
5.376800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.343600E-01
Normal-vs-Female
4.009000E-01
Male-vs-Female
3.481600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.413800E-01
Normal-vs-Age(41-60Yrs)
2.701400E-01
Normal-vs-Age(61-80Yrs)
4.075400E-01
Normal-vs-Age(81-100Yrs)
5.110800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.849800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.371000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.038600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.941800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.822800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.639400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.388400E-01
Normal-vs-Daily Drinker
4.309200E-01
Normal-vs-Weekly Drinker
4.314600E-01
Normal-vs-Occasional Drinker
4.610200E-01
Normal-vs-Social Drinker
3.649600E-01
Non Drinker-vs-Daily Drinker
5.768000E-01
Non Drinker-vs-Weekly Drinker
7.850400E-01
Non Drinker-vs-Occasional Drinker
6.056000E-01
Non Drinker-vs-Social Drinker
2.635800E-01
Daily Drinker-vs-Weekly Drinker
8.454000E-01
Daily Drinker-vs-Occasional Drinker
9.971600E-01
Daily Drinker-vs-Social Drinker
6.411400E-01
Weekly Drinker-vs-Occasional Drinker
8.544200E-01
Weekly Drinker-vs-Social Drinker
5.711000E-01
Occasional Drinker-vs-Social Drinker
6.792200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.279760E-01
Normal-vs-Grade 2
5.743700E-02
Normal-vs-Grade 3
4.656600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.183030E-01
Grade 1-vs-Grade 3
3.713000E-01
Grade 1-vs-Grade 4
1.279760E-01
Grade 2-vs-Grade 3
2.526400E-01
Grade 2-vs-Grade 4
5.743700E-02
Grade 3-vs-Grade 4
4.656600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.891200E-01
Normal-vs-NonDiabetic
3.228400E-01
Diabetic-vs-NonDiabetic
2.549000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.311600E-01
Normal-vs-NoPancreatitis
4.116400E-01
Pancreatitis-vs-NoPancreatitis
7.282800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.322200E-01
Normal-vs-N1
3.203400E-01
N0-vs-N1
3.419800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.897800E-02
Normal-vs-TP53-NonMutant
3.638800E-01
TP53-Mutant-vs-TP53-NonMutant
1.811500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
